COMMUNIQUÉS West-GlobeNewswire

FDA Approves New Indication for ENVARSUS XR® (tacrolimus extended-release tablets)
19/12/2018
Company Release no. 22/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 19 December 2018 FDA Approves New Indication for ENVARSUS XR ® (tacrolimus extended-release tablets) Veloxis Pharmaceuticals announced today [...]
Clearside Biomedical Submits New Drug Application for XIPERE™ for the Treatment of Macular Edema Associated with Uveitis
19/12/2018
ALPHARETTA, Ga., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Soleno Therapeutics Announces $16.5 Million Private Placement
19/12/2018
Financing Led by Abingworth; Andrew Sinclair, Partner, to Join Soleno’s Board Funding to Support Ongoing Phase III Clinical Program (DESTINY PWS) for DCCR in Prader-Willi Syndrome REDWOOD CITY, Calif., Dec. 19, 2018 ( [...]
MannKind Announces Commencement of Public Offering
19/12/2018
WESTLAKE VILLAGE, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) (MannKind) today announced that it has commenced an underwritten public offering to issue and sell shares of its common [...]
G1 Therapeutics Announces Positive Topline Results from Randomized Phase 2 Trial of Trilaciclib Showing Multi-Lineage Myelopreservation Benefits in 2nd-/3rd-Line Small Cell Lung Cancer
19/12/2018
Achieved both primary endpoints: statistically significant reductions in the duration and occurrence of Grade 4 neutropenia Clinically meaningful reductions in rates of granulocyte-colony stimulating factor (G-CSF) [...]
Amicus Therapeutics Announces Executive Team Updates
19/12/2018
Daphne Quimi Promoted to Chief Financial Officer David Clark Joins as Chief People Officer Ellen Rosenberg Promoted to Chief Legal Officer CRANBURY, N.J., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: [...]
AgraFlora Organics 2.2 Million Square Foot Delta Facility is the Second Largest Cannabis Greenhouse in Canada
19/12/2018
VANCOUVER, British Columbia, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Agraflora Organics International Inc. (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF) (formerly PUF Ventures Inc.) released a three stage timeline last week [...]
NeuroMetrix to Present at Upcoming Biotech Showcase 2019 In San Francisco
19/12/2018
WALTHAM, Mass., Dec. 19, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be presenting at the Biotech Showcase 2019 [...]
BRACAnalysis CDx® Approved by U.S. Food and Drug Administration as Companion Diagnostic for AstraZeneca’s Lynparza® (olaparib) in Patients with Advanced-Stage, BRCA-Mutated Ovarian Cancer
19/12/2018
SALT LAKE CITY, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, today announced that the U.S. Food and Drug Administration (FDA) has [...]
AB Science provides an update on the restructuring of its clinical development department in 2018
19/12/2018
Paris, December 19, 2018, 6pm Update on restructuring of the AB Science clinical development department in 2018 AB Science SA (NYSE Euronext - FR0010557264 - AB), a pharmaceutical company specialized in the research and [...]
AB Science fait le point sur sa réorganisation du développement clinique en 2018
19/12/2018
Paris, 19 décembre 2018, 18h Point sur la réorganisation du développement clinique d'AB Science en 2018 AB Science SA (NYSE Euronext - FR0010557264 - AB), société pharmaceutique spécialisée dans la recherche et le [...]
2018: A Year of Achievements for NYMOX
19/12/2018
HASBROUCK HEIGHTS, N.J., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Following the Nymox (NASDAQ: NYMX) Annual General Meeting yesterday (December 18, 2018), Nymox management discussed many significant 2018 events and commented [...]
Coherus BioSciences Announces New Employment Inducement Grants
19/12/2018
REDWOOD CITY, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective December 18, 2018, the compensation committee of the company’s board of directors granted [...]
ADMA Biologics Provides Regulatory Update for BIVIGAM®
19/12/2018
FDA PDUFA Action Anticipated RAMSEY, N.J. and BOCA RATON, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), announces that as of the time of this press release the [...]
Eyenovia Prices Public Offering of Common Stock
19/12/2018
NEW YORK, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (“Eyenovia” or the “Company”) (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing [...]
Hemp Legalization Bodes Well for Alkaline Water Co. -- CFN Media
19/12/2018
SEATTLE, Dec. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Phoenix Life Sciences International Announces Doctor Mohyuddin Mirza as Company's New Botany Specialist
19/12/2018
DENVER, CO, Dec. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that [...]
CV Sciences, Inc. Featured as a Panelist at 2nd Annual Neuroscience Innovation Forum in San Francisco
19/12/2018
Forum to cover partnerships, industry keynotes and influential medical panels LAS VEGAS, Dec. 19, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB: CVSI) preeminent supplier and manufacturer of its industry dominating [...]
Teladoc Health to Participate in Upcoming Investor Conference
19/12/2018
PURCHASE, NY, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Jason Gorevic, chief executive officer, will participate in the following [...]

Pages